The identification of the Ian5 gene as the candidate Iddm2/lyp gene as has opened a new set of questions addressing the particular function of this gene in lymphopenia and its relation to the development of autoimmune diabetes. The knowledge about of Ian5, and of the other members of this gene family is still fragmentary, but seems to involve common themes, such as the ability to regulate apoptosis, to bind GTP, and to by associated with immune cells. It is not known how these emerging activities of Ian 5 are tied to the development of lymphopenia and type 1 diabetes, and whether both lymphopenia and autoimmune diabetes are merely epiphenomena or are indeed causally linked. Evolutionary divergence of the Ian gene family has further led to the presence of a paralog of Ian5, termed Ian4, in both humans and mice, but not in rats. Here, we investigate the specific function of the first identified candidate iddm2 gene, Ian5, in the development of immune diabetes. Specifically, we will utilize transgenic rescue of the lyp-phenotype in BB-DP rats to establish formal proof that the loss of Ian5 function is the sole cause of lymphopenia and autoimmune diabetic disease;Second, we will generate a mouse model of Ian5 deficiency and test the hypothesis that Ian5 prevents lymphopenia and autoimmune disease by inhibiting apoptosis of regulatory T cells induced by the ART2/Rt6-dependent activation of the P2X7 receptor by ribosylated nucleotides. Third, in order to gain first insights into the molecular interactions that couple Ian5 function to the inhibition of apoptosis and autoimmune disease, we will conduct an in vivo structure-function analysis of Ian5. Results from these experiments are expected to delineate the molecular and pathophysiological mechanism that control the survival of regulatory T cells and lead to autoimmune diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI042380-13
Application #
7764680
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
13
Fiscal Year
2009
Total Cost
$253,186
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Jokinen, Riikka; Lahtinen, Taina; Marttinen, Paula et al. (2015) Quantitative changes in Gimap3 and Gimap5 expression modify mitochondrial DNA segregation in mice. Genetics 200:221-35
Bogdani, Marika; Henschel, Angela M; Kansra, Sanjay et al. (2013) Biobreeding rat islets exhibit reduced antioxidative defense and N-acetyl cysteine treatment delays type 1 diabetes. J Endocrinol 216:111-23
Moralejo, Daniel; Yanay, Ofer; Kernan, Kelly et al. (2011) Sustained glucagon-like peptide 1 expression from encapsulated transduced cells to treat obese diabetic rats. J Biosci Bioeng 111:383-7
Moralejo, Daniel H; Fuller, Jessica M; Rutledge, Elizabeth A et al. (2011) BB rat Gimap gene expression in sorted lymphoid T and B cells. Life Sci 89:748-54
Yanay, Ofer; Moralejo, Daniel; Kernan, Kelly et al. (2010) Prolonged survival and improved glycemia in BioBreeding diabetic rats after early sustained exposure to glucagon-like peptide 1. J Gene Med 12:538-44
Moralejo, Daniel H; Hansen, Carl T; Treuting, Piper et al. (2010) Differential effects of leptin receptor mutation on male and female BBDR Gimap5-/Gimap5- spontaneously diabetic rats. Physiol Genomics 41:9-20
Kaldunski, Mary; Jia, Shuang; Geoffrey, Rhonda et al. (2010) Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat. Diabetes 59:2375-85
Rutledge, Elizabeth A; Fuller, Jessica M; Van Yserloo, Brian et al. (2009) Sequence variation and expression of the Gimap gene family in the BB rat. Exp Diabetes Res 2009:835650
Fuller, J M; Bogdani, M; Tupling, T D et al. (2009) Genetic dissection reveals diabetes loci proximal to the gimap5 lymphopenia gene. Physiol Genomics 38:89-97
Schulteis, Ryan D; Chu, Haiyan; Dai, Xuezhi et al. (2008) Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5. Blood 112:4905-14

Showing the most recent 10 out of 38 publications